Relay Therapeutics, Inc.

Healthcare · Biotechnology · United States

Last price 19.47 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 4.27B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It transforms the drug discovery process with a focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company’s lead product candidates include RLY-2608, a pan-mutant and isoform-selective phosphoinostide 3 kinase alpha, or PI3Kα, inhibitor that is in clinical development for the treatment of breast cancer, solid tumor, and vascular malformations; and αGal chaperone for Fabry diseases. It also develops R...